Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Researchers made new compounds that could potentially be developed into anticancer drugs.

New compounds were made that are promising for prostate cancer therapy.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

New method makes important drug ingredients more easily without needing extra purification steps.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Compound 1 showed promising anticancer activity.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

The compound 4c showed strong potential as an anticancer agent.

The salts have diverse molecular packing with significant hydrogen interactions.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.